Is the Verification Phase a Suitable Criterion for the Determination of Maximum Oxygen Uptake in Patients with Heart Failure and Reduced Ejection Fraction? A Validation Study

Agustín Manresa-Rocamora, Laura Fuertes-Kenneally, Carles Blasco-Peris, Noemí Sempere-Ruiz, José Manuel Sarabia () and Vicente Climent-Paya
Additional contact information
Agustín Manresa-Rocamora: Institute for Health and Biomedical Research of Alicante (ISABIAL), 03010 Alicante, Spain
Laura Fuertes-Kenneally: Institute for Health and Biomedical Research of Alicante (ISABIAL), 03010 Alicante, Spain
Carles Blasco-Peris: Institute for Health and Biomedical Research of Alicante (ISABIAL), 03010 Alicante, Spain
Noemí Sempere-Ruiz: Institute for Health and Biomedical Research of Alicante (ISABIAL), 03010 Alicante, Spain
José Manuel Sarabia: Institute for Health and Biomedical Research of Alicante (ISABIAL), 03010 Alicante, Spain
Vicente Climent-Paya: Institute for Health and Biomedical Research of Alicante (ISABIAL), 03010 Alicante, Spain

IJERPH, 2023, vol. 20, issue 4, 1-10

Abstract: The verification phase (VP) has been proposed as an alternative to the traditional criteria used for the determination of the maximum oxygen uptake (VO 2 max) in several populations. Nonetheless, its validity in patients with heart failure with reduced ejection fraction (HFrEF) remains unclear. Therefore, the aim of this study was to analyse whether the VP is a safe and suitable method to determine the VO 2 max in patients with HFrEF. Adult male and female patients with HFrEF performed a ramp-incremental phase (IP), followed by a submaximal constant VP (i.e., 95% of the maximal workload during the IP) on a cycle ergometer. A 5-min active recovery period (i.e., 10 W) was performed between the two exercise phases. Group (i.e., median values) and individual comparisons were performed. VO 2 max was confirmed when there was a difference of ≤ 3% in peak oxygen uptake (VO 2 peak) values between the two exercise phases. Twenty-one patients (13 males) were finally included. There were no adverse events during the VP. Group comparisons showed no differences in the absolute and relative VO 2 peak values between both exercise phases ( p = 0.557 and p = 0.400, respectively). The results did not change when only male or female patients were included. In contrast, individual comparisons showed that the VO 2 max was confirmed in 11 patients (52.4%) and not confirmed in 10 (47.6%). The submaximal VP is a safe and suitable method for the determination of the VO 2 max in patients with HFrEF. In addition, an individual approach should be used because group comparisons could mask individual differences.

Keywords: cardiorespiratory fitness; VO 2 max; HFrEF; exercise testing; respiratory exchange ratio; gradual exercise test; VO 2 peak (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/20/4/2764/pdf (application/pdf)
https://www.mdpi.com/1660-4601/20/4/2764/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:20:y:2023:i:4:p:2764-:d:1057602

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().